Funded Tech Companies
Triumvira Immunologics
Wondering who provided funding to Triumvira Immunologics? Leaps by Bayer, B Capital Group and ATEM Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Triumvira Immunologics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Crystal Mountain At Barton Creek
Austin, TX 78733
USA
Austin, TX 78733
USA
Phone
Website
Email Address
Company Background Information
Overview
Triumvira Immunologics, Inc. (Triumvira) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/17/2022
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Lammers
Chief Medical Officer
Sabine Chlosta
Chief Scientific Officer
Jonathan Bramson
Chief Technical Officer
Donna Rill
VP - Bus. Development
Joshua Carle
VP - Finance
Jon Irvin
VP - R & D
Andreas Bader
VP - Regulatory Affairs
Cynthia Molina
Company Investors
- Leaps by Bayer (Juergen Eckhardt)
- B Capital Group
- ATEM Capital
- Northpond Ventures (Michael Rubin)
- Myeloma Investment Fund
- Ocean Pine Healthcare Fund
- Viva Ventures Biotech
- Bloom Burton
- Centre for Commercialization of Cancer Immunotherapy (C3i)
Browse more funded tech companies:
Triumph Labs | Trius Therapeutics
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs